Erosive Esophagitis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Different dosages of vonoprazan for gastroesophageal reflux disease: study protocol for a pragmatic, crossover-cluster, randomized controlled trial with patient preference arms
This study aims to investigate whether vonoprazan could relieve the symptoms of Chinese patients with non-erosive reflux disease (NERD) and whether increased dosage or different times of dosing could increase t he response rate of GERD.MethodsThis study is a pragmatic, open-label, crossover-cluster, randomized controlled trial with patient preference arms. Two thousand eight hundred eighty patients with GERD from 48 hospitals in China will be enrolled. These hospitals will be divided into a compulsory randomization cluster (24 hospitals) and a patient preference cluster (24 hospitals). Patients in the compulsory randomizat...
Source: Trials - December 1, 2023 Category: Research Source Type: clinical trials

A Phase 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis
Condition: Erosive Esophagitis Interventions: Drug: BLI5100; Drug: PPI Control Sponsor: Braintree Laboratories Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2022 Category: Research Source Type: clinical trials

JP-1366 20mg Versus Esomeprazole 40mg in Patients With Erosive Esophagitis
Condition: Erosive Esophagitis Interventions: Drug: Experimental drug; Drug: Active comparative drug Sponsor: Onconic Therapeutics Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 5, 2022 Category: Research Source Type: clinical trials